SE9800016D0 - Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den - Google Patents

Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den

Info

Publication number
SE9800016D0
SE9800016D0 SE9800016A SE9800016A SE9800016D0 SE 9800016 D0 SE9800016 D0 SE 9800016D0 SE 9800016 A SE9800016 A SE 9800016A SE 9800016 A SE9800016 A SE 9800016A SE 9800016 D0 SE9800016 D0 SE 9800016D0
Authority
SE
Sweden
Prior art keywords
pct
antimycotic
preparation
imidazolylacetonitrile
dithiolan
Prior art date
Application number
SE9800016A
Other languages
English (en)
Swedish (sv)
Other versions
SE9800016L (sv
Inventor
Niroki Kodama
Yoshimi Niwano
Kazuo Kanai
Masanori Yoshida
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of SE9800016L publication Critical patent/SE9800016L/xx
Publication of SE9800016D0 publication Critical patent/SE9800016D0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE9800016A 1995-07-08 1998-01-07 Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den SE9800016D0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP19617495 1995-07-08
PCT/JP1996/001872 WO1997002821A2 (fr) 1995-07-08 1996-07-05 Agent antifongique, son compose, son procede de production

Publications (2)

Publication Number Publication Date
SE9800016L SE9800016L (sv) 1998-01-07
SE9800016D0 true SE9800016D0 (sv) 1998-01-07

Family

ID=16353435

Family Applications (1)

Application Number Title Priority Date Filing Date
SE9800016A SE9800016D0 (sv) 1995-07-08 1998-01-07 Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den

Country Status (22)

Country Link
US (1) US5900488A (fr)
EP (1) EP0839035B1 (fr)
KR (1) KR100386491B1 (fr)
CN (1) CN1091596C (fr)
AT (1) AT407832B (fr)
CA (1) CA2226214C (fr)
CH (1) CH692045A5 (fr)
DE (1) DE19681478B4 (fr)
DK (1) DK176599B1 (fr)
ES (1) ES2137888B1 (fr)
FI (1) FI119357B (fr)
GB (1) GB2317615B (fr)
HK (1) HK1009751A1 (fr)
IL (1) IL122618A (fr)
IN (1) IN185384B (fr)
LU (1) LU90190B1 (fr)
NO (1) NO980055L (fr)
NZ (1) NZ311796A (fr)
SE (1) SE9800016D0 (fr)
TW (1) TW450969B (fr)
WO (1) WO1997002821A2 (fr)
ZA (1) ZA965745B (fr)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127397A (en) * 1996-12-10 2000-10-03 Nihon Nohyaku Co., Ltd. Optically active (R)-(E)-(4-substituted-phenyl-1,3-dithiolan-2-ylidene)-1-imidazolylaceto nitrile derivative, antifungal composition comprising the same, and method for producing the same
US8039452B2 (en) * 2002-06-18 2011-10-18 Pola Pharma Inc. Antifungal medicinal compositions
WO2003105903A1 (fr) * 2002-06-18 2003-12-24 ポーラ化成工業株式会社 Composition medicinale fongicide
AU2006339841B2 (en) 2006-03-08 2012-08-30 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
AU2006339842B2 (en) 2006-03-08 2012-06-07 Nihon Nohyaku Co., Ltd. Pharmaceutical composition for external use
WO2007102243A1 (fr) * 2006-03-08 2007-09-13 Nihon Nohyaku Co., Ltd. Composition pharmaceutique externe
EP2191825B8 (fr) 2007-08-27 2016-09-21 Nihon Nohyaku Co., Ltd. Agent pour une dermatite fongique
WO2009031644A1 (fr) 2007-09-05 2009-03-12 Pola Pharma Inc. Composition pharmaceutique antifongique
JP5529539B2 (ja) * 2007-09-05 2014-06-25 株式会社ポーラファルマ 医薬組成物
EP2191827B1 (fr) 2007-09-05 2013-10-30 Pola Pharma Inc. Composition antifongique
EP2745692A1 (fr) * 2009-02-13 2014-06-25 Topica Pharmaceuticals, Inc Formulation antifongique contenant du luliconalzole
US9050271B2 (en) 2009-04-09 2015-06-09 Pola Pharma Inc. Antimycotic pharmaceutical composition
WO2010117089A2 (fr) 2009-04-09 2010-10-14 Pola Pharma Inc. Composition pharmaceutique antimycotique
EP2470178B1 (fr) 2009-08-25 2018-10-17 Pola Pharma Inc. Composition pharmaceutique antimycotique
EP2579847A1 (fr) 2010-06-11 2013-04-17 Pola Pharma Inc. Composition pharmaceutique antimycosique
CN103012385B (zh) * 2012-02-17 2015-07-08 山东威智医药工业有限公司 卢立康唑的晶型及其制备方法
JP5460797B1 (ja) 2012-09-14 2014-04-02 株式会社ポーラファルマ アミド誘導体及び安定性指標としてのその使用
RU2622644C2 (ru) * 2012-09-14 2017-06-19 Пола Фарма Инк. Кристаллическое вещество и содержащий его фармацевтический препарат
US9068958B1 (en) 2012-09-14 2015-06-30 Pola Pharma Inc. Use of surface free energy for differential evaluation of crystal, crystal evaluated on basis of surface free energy as index, and pharmaceutical composition prepared by containing the crystal
EP2895479A1 (fr) * 2012-09-14 2015-07-22 Pola Pharma Inc. Cristal ayant des habitus cristallins et composition pharmaceutique obtenue par traitement du cristal
CN104968344A (zh) * 2013-01-28 2015-10-07 宝丽制药股份有限公司 针对由病原微生物诸如念珠菌引起的疾病的药物组合物
JP6279583B2 (ja) * 2013-01-28 2018-02-14 株式会社ポーラファルマ アスペルギルス等の病原微生物による疾患用の医薬組成物
JP5589110B1 (ja) 2013-03-08 2014-09-10 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5680161B1 (ja) * 2013-09-06 2015-03-04 株式会社ポーラファルマ 晶癖を有する結晶及び該結晶を有効成分として含有する医薬組成物
JP5587488B1 (ja) 2013-12-12 2014-09-10 株式会社ポーラファルマ ルリコナゾールを含有する製剤の評価方法及び指標物質
AR100180A1 (es) * 2014-04-25 2016-09-14 Syngenta Participations Ag Derivados de imidazol microbiocidas
WO2016092478A1 (fr) 2014-12-12 2016-06-16 Glenmark Pharmaceuticals Limited Procédé de préparation de luliconazole
WO2017108972A1 (fr) 2015-12-21 2017-06-29 Laboratorios Lesvi, S.L. Composés de r-(-)-(e)-[4-(2,4-dichlorophényl)-1,3-dithiolan-2-ylidène]-1-imidazolylacétonitrile-ha (luliconazole-ha) à titre d'antifongiques
CN106008166B (zh) * 2016-05-17 2018-09-25 上海福乐医药科技有限公司 一种手性2-氯-1-(2,4-二氯苯基)乙醇的工业化生产方法
US11185548B2 (en) 2016-12-23 2021-11-30 Helmholtz Zentrum Munchen—Deutsches Forschungszentrum Für Gesundheit Und Umwelt (Gmbh) Inhibitors of cytochrome P450 family 7 subfamily B member 1 (CYP7B1) for use in treating diseases
TR201714882A2 (tr) 2017-10-03 2019-04-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Luli̇konazolün topi̇kal farmasöti̇k kompozi̇syonlari
US10898470B1 (en) 2019-08-13 2021-01-26 Sato Pharmaceutical Co., Ltd. Pharmaceutical composition containing antifungal agent as active ingredient
WO2023131969A1 (fr) * 2022-01-09 2023-07-13 Kimia Biosciences Limited Procédé amélioré pour la préparation de luliconazole

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218736B1 (fr) * 1985-10-10 1993-04-07 Nihon Nohyaku Co., Ltd. Dérivé de cétène-S,S-acétal, procédé pour sa préparation et méthode pour guérir la mycose utilisant ce dérivé
DE3587252T2 (de) * 1985-10-09 1993-07-15 Nihon Nohyaku Co Ltd Keten-s,s,-acetalderivate, verfahren zu ihrer herstellung und methode zur heilung von mykose unter verwendung dieser derivate.
JP3030780B2 (ja) * 1988-12-29 2000-04-10 日本農薬株式会社 光学活性なケテンジチオアセタール誘導体及びその製造方法
JPH0386337A (ja) * 1989-08-28 1991-04-11 Maeda Seisakusho:Kk エクスパンディングチャックを用いた多重巻締め機および多重巻締め方法
CN1038247C (zh) * 1990-05-16 1998-05-06 云南省建筑材料科学研究设计院 一种新型磷石膏胶结料
JP3038519B2 (ja) * 1992-01-28 2000-05-08 日本農薬株式会社 創傷治癒促進剤

Also Published As

Publication number Publication date
TW450969B (en) 2001-08-21
NO980055L (no) 1998-03-06
DK176599B1 (da) 2008-10-27
ES2137888A1 (es) 1999-12-16
GB9726766D0 (en) 1998-02-18
FI119357B (fi) 2008-10-31
DE19681478B4 (de) 2006-09-21
NZ311796A (en) 1999-06-29
LU90190B1 (de) 1998-03-02
HK1009751A1 (en) 1999-06-11
ES2137888B1 (es) 2001-01-01
DE19681478T1 (de) 1998-07-02
EP0839035B1 (fr) 2002-10-02
CH692045A5 (de) 2002-01-15
FI980023A0 (fi) 1998-01-07
AU697571B2 (en) 1998-10-08
AT407832B (de) 2001-06-25
CA2226214A1 (fr) 1997-01-30
SE9800016L (sv) 1998-01-07
US5900488A (en) 1999-05-04
MX9710401A (es) 1998-07-31
NO980055D0 (no) 1998-01-06
IN185384B (fr) 2001-01-13
ZA965745B (en) 1997-01-27
FI980023A (fi) 1998-01-07
IL122618A0 (en) 1998-08-16
GB2317615A (en) 1998-04-01
KR19990028772A (ko) 1999-04-15
EP0839035A2 (fr) 1998-05-06
KR100386491B1 (ko) 2003-08-21
CA2226214C (fr) 2007-04-17
CN1091596C (zh) 2002-10-02
ATA906196A (de) 2000-11-15
CN1194582A (zh) 1998-09-30
DK1398A (da) 1998-01-07
WO1997002821A2 (fr) 1997-01-30
GB2317615B (en) 1998-09-02
AU6319296A (en) 1997-02-10
WO1997002821A3 (fr) 1997-02-20
IL122618A (en) 2002-07-25

Similar Documents

Publication Publication Date Title
SE9800016D0 (sv) Antimykotikum, förening därför, förfarande för framställning av den och metod för användning av den
LU91145I2 (fr) FIROCOXIB facultativement sous forme d'un sel pharmaceutiquement acceptable (PREVICOX).
PT958296E (pt) Compostos heterociclicos processo para a sua preparacao composicoes farmaceuticas contendo-os e sua utilizacao no tratamento da diabetes e doencas relacionadas
DK0808318T3 (da) Tricykliske, substituerede hexahydrobenz[e]isoindol-alfa-1-adrenerge antagonister
SE9404080L (sv) Förfarande för framställning av en optiskt ren enantiomer av formoterol
IL115920A0 (en) 2,2-dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these
ES2159721T3 (es) Antagonistas alfa-1-adrenergicos biciclicos sustituidos de hexahidrobenz(e)isoindol.
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
ATE200423T1 (de) Verwendung von 1-(2-naphtylethyl)-4-(3- trifluoromethylphenyl)-1,2,3,6-tetrahydropyridi zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
DE69706382T2 (de) Verfahren zur herstellung von 2,2'-bipyrrolyl-pyrromethen-derivaten (prodigiosine)
DE3686979D1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
IS2274B (is) Aðferð til að búa til kamptóþesín afleiður
ATE252586T1 (de) 8-substituierte-9h-1,3-dioxolo/4,5-h//2, 3/benzodiazepin derivate als ampa/kainate- rezeptor-hemmer
DK0823909T3 (da) Hidtil ukendte heterocykliske forbindelser
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
DE69627533T2 (de) Herstellung von einem kristallinen amoxicillinsalz
ATE238286T1 (de) Neue triazole als therapeutische mittel gegen pilzinfektionen
DE69905490T2 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
TNSN98190A1 (fr) Derive d'indole utile en therapeutique, procede pour sa production et formulation pharmaceutique le contenant
GR3031544T3 (en) New derivatives of pyridine or pyridazine, process for production thereof and medicaments containing these compounds
ATE188694T1 (de) Verfahren zur herstellung von benzopyranderivaten
HUP0201181A2 (hu) 1,5-Benzodiazepin-származék előállítása és az ezt tartalmazó gyógyszerkészítmény
DE69614838D1 (de) Verfahren zur herstellung von anhydroecgonin-estern
DE59504077D1 (de) Neue 2.4-diphosphonoglutarsäurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
TH20641A (th) 6-[ไทรแอโซลิล[3-(ไทรฟลูออโรเมธิล)เฟนิล]เมธิล]-2-ควิโนลิโนนและ-ควิโนลีนไธโอน

Legal Events

Date Code Title Description
NAV Patent application has lapsed

Ref document number: 9800016-9

Format of ref document f/p: F